Disclosure Statement

You must select "I Understand" to see results.

The physicians in our directory are members of a Children’s Health hospital medical staff or are credentialed by Children’s Health for managed care participation. Some physicians are employed by Children’s Health, some are employed elsewhere, and some maintain an independent medical practice. There is no fee for being listed in our directory. The physicians populating your search results are selected based on the criteria that you provide and are then listed alphabetically. If a physician is no longer on a Children’s Health medical staff or participating in a Children’s Health managed care agreement, he/she would not be eligible to be listed in our directory.

Raksha Jain, MD $$

Pediatric Pulmonologist

Professor at UT Southwestern Medical Center

Languages Spoken:
English Hindi,Spanish
UT Southwestern Pediatric Group

Education and Training

Medical School
University of Texas Health Science Center at Houston (2001)
Residency
UT Southwestern Medical Center (HR) (2005), Internal Medicine
UT Southwestern Medical Center (HR) (2004), Internal Medicine
Fellowship
Washington University (2009), Pulmonary Medicine
Graduate School
Washington University School of Medicine (2010)
Board Certification
American Board of IM/Pulmonary Disease
  • Research Interests

    • Gender disparities in lung diseases
    • Hormonal influences on airway epithelium
    • Treatment advances for Cystic Fibrosis
  • Publications

    • Concentrations of dehydroepiandrosterone-sulphate (DHEA-S) in people with cystic fibrosis on and off elexacaftor-tezacaftor-ivacaftor. Abid S, Shaffer L, Bayat A, Lee M, Keller A, Jain R Journal of Cystic Fibrosis 2024 Sep 23 874-877
    • Prioritizing sexual and reproductive health research and care for people with cystic fibrosis: A 2023 workshop report from the Cystic Fibrosis Foundation Sexual Health, Reproduction, and Gender (SHARING) Research Working Group. Kazmerski TM, Moy C, Aliaj E, Hudson J, Wright B, Poranski M, Sjoberg J, Taylor-Cousar JL, Georgiopoulos AM, Ladores SL, Trimble A, Tangpricha V, Khan FN, Ramasamy R, Leitner DV, West NE, Santos RD, Stransky OM, Wilson A, Keller A, Jain R Journal of Cystic Fibrosis 2024 Jul 23 639-646
    • In vivo editing of lung stem cells for durable gene correction in mice. Sun Y, Chatterjee S, Lian X, Traylor Z, Sattiraju SR, Xiao Y, Dilliard SA, Sung YC, Kim M, Lee SM, Moore S, Wang X, Zhang D, Wu S, Basak P, Wang J, Liu J, Mann RJ, LePage DF, Jiang W, Abid S, Hennig M, Martinez A, Wustman BA, Lockhart DJ, Jain R, Conlon RA, Drumm ML, Hodges CA, Siegwart DJ Science (New York, N.Y.) 2024 Jun 384 1196-1202
    • A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancy. Taylor-Cousar JL, Janney R, Middleton PG, Jain R, Nightingale J, West NE, Shteinberg M, Velez D, Kazmerski TM Journal of Cystic Fibrosis 2024 May 23 412-416
    • Clinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosis. Kazmerski TM, Stransky OM, Lavage DR, Hughan KS, Jain R, Ladores SL, Stalvey MS, Tangpricha V, Taylor-Cousar JL, West NE, Sawicki GS Journal of Cystic Fibrosis 2024 May 23 417-423
    • The impact of switching to race-neutral reference equations on FEV1 percent predicted among people with cystic fibrosis. Rosenfeld M, Cromwell EA, Schechter MS, Ren C, Flume PA, Szczesniak RD, Morgan WJ, Jain R Journal of Cystic Fibrosis 2024 May 23 443-449
    • Factors associated with pubertal growth outcomes in cystic fibrosis: Early Growth and Puberty in CF. Patil R, Magaret AS, Jain R, Taylor-Cousar J, Hughan KS, Kazmerski TM Journal of Cystic Fibrosis 2024 May 23 538-544
    • Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. Wang A, Lee MJ, Keller A, Jian S, Lowe K, Finklea JD, Jain R Journal of Cystic Fibrosis 2024 Jan 23 91-98
    • The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis. Jain R, Kazmerski TM, Taylor-Cousar JL Current Opinion in Pulmonary Medicine 2023 Nov 29 595-602
    • Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective. Mayer-Hamblett N, Clancy JP, Jain R, Donaldson SH, Fajac I, Goss CH, Polineni D, Ratjen F, Quon BS, Zemanick ET, Bell SC, Davies JC, Jain M, Konstan MW, Kerper NR, LaRosa T, Mall MA, McKone E, Pearson K, Pilewski JM, Quittell L, Rayment JH, Rowe SM, Taylor-Cousar JL, Retsch-Bogart G, Downey DG The Lancet Respiratory Medicine 2023 Oct 11 932-944
    • Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis. Peng G, Taylor-Cousar JL, Lee MJ, Keller A, West NE, Kazmerski TM, Goralski JL, Aitken ML, Roe AH, Hadjiliadis D, Uluer A, Flume PA, Mody S, Bray LA, Jain R Journal of Cystic Fibrosis 2023 Sep 22 796-803
    • Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. Author Collaboration V, Author Collaboration VS, Uluer AZ, MacGregor G, Azevedo P, Indihar V, Keating C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Rubenstein RC, Taylor-Cousar JL, Tullis E, Yonker LM, Chu C, Lam AP, Nair N, Sosnay PR, Tian S, Van Goor F, Viswanathan L, Waltz D, Wang LT, Xi Y, Billings J, Horsley A, Nash EF, Bakker M, van der Meer R, Merkus P, Majoor C, McCoy K, Pancham K, Tolle J, Quick B, Uluer A, DiMango E, Rao A, Reyes S, Klingsberg R, Barreto C, Ortega V, Willey-Courand D, Schwarz C, Sutharsan S, Fischer R, Davies J, Duckers J, Doe S, Heijerman H, Jain R The Lancet Respiratory Medicine 2023 Jun 11 550-562
    • Chronic Pancreatitis Associated With a Variant of CFTR Gene Treated With Total Pancreatectomy and Autologous Islet Cell Transplantation. Agarwal S, Lingvay I, Mirfakhraee S, Jain R AACE Clinical Case Reports 2023 May 9 93-96
    • Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Author Collaboration SS, Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH, Kloster M, Weaver K, Chapdu C, Xie J, Skalland M, Romasco M, Heltshe S, Simon N, VanDalfsen J, Mead A, Buckingham R, Seidel K, Midamba N, Couture L, Case BZ, Au W, Rockers E, Cooke D, Olander A, Bondick I, Johnson M, VanHousen L, Nicholson B, Parrish M, Roberts D, Head J, Jain R, Sharma P The Lancet Respiratory Medicine 2023 Apr 11 329-340
    • Menopause in people with cystic fibrosis. Prochownik K, Jain R, Taylor-Cousar JL, Lavage DR, Stransky OM, Thomas HN, Kazmerski TM Menopause 2023 Apr 30 401-405
    • The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis. Taylor-Cousar JL, Shteinberg M, Cohen-Cymberknoh M, Jain R Clinical Therapeutics 2023 Mar 45 278-289
    • Clinician attitudes and practices on pregnancy planning and care in cystic fibrosis. Montemayor K, Kazmerski TM, Riekert KA, Psoter KJ, Jain R, Taylor-Cousar JL, Aitken ML, Boyle RL, Patel S, West NE Journal of Cystic Fibrosis 2023 Mar 22 201-206
    • Partner perspectives on women's sexual and reproductive healthcare in cystic fibrosis. Ehrenberg S, Stransky OM, Wright CE, Jain R, Kazmerski TM Journal of Cystic Fibrosis 2023 Mar 22 217-222
    • Sexual and reproductive health experiences and care of adult women with cystic fibrosis. Kazmerski TM, Stransky OM, Lavage DR, Taylor-Cousar JL, Sawicki GS, Ladores SL, Godfrey EM, Aitken ML, Fields A, Sufian S, Jain M, Barto TL, Billings J, Hadjiliadis D, Jain R Journal of Cystic Fibrosis 2023 Mar 22 223-233
    • Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor. Patel P, Yeley J, Brown C, Wesson M, Lesko BG, Slaven JE, Chmiel JF, Jain R, Sanders DB International Journal of Neonatal Screening 2023 Mar 9
    • SEXUAL HEALTH, FERTILITY, AND PREGNANCY IN PEOPLE WITH CYSTIC FIBROSIS. Jain R, Sawyer SM, Cohen-Cymberknoh M 2023 Jan 415-425
    • Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosis. Abid S, Lee MJ, Rodich B, Hook JS, Moreland JG, Towler D, Maalouf NM, Keller A, Ratti G, Jain R Journal of Cystic Fibrosis 2023 Jan 22 140-145
    • Family Planning and Reproductive Health in Cystic Fibrosis. Meiss LN, Jain R, Kazmerski TM Clinics in Chest Medicine 2022 Dec 43 811-820
    • Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding. Jain R, Wolf A, Molad M, Taylor-Cousar J, Jr CR, Shteinberg M Journal of Cystic Fibrosis 2022 Nov 21 1074-1076
    • Cystic Fibrosis: Highly Effective Targeted Therapeutics and the Impact on Sex and Racial Disparities. Montemayor K, Jain R Medical Clinics of North America 2022 Nov 106 1001-1012
    • Changes in Care during the COVID-19 Pandemic for People with Cystic Fibrosis. Sanders DB, Wu R, O'Neil T, Elbert A, Petren K, Jain R, Ren CL Annals of the American Thoracic Society 2022 Oct 19 1697-1703
    • Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening. Ratti GA, Fernandez GS, Schechter MS, Stalvey MS, Ostrenga J, Fink AK, Jain R Journal of Cystic Fibrosis 2022 Sep 21 784-791
    • Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry. Szentpetery S, Fernandez GS, Schechter MS, Jain R, Flume PA, Fink AK Journal of Cystic Fibrosis 2022 Sep 21 777-783
    • Parenthood impacts short-term health outcomes in people with cystic fibrosis. Kazmerski TM, Jain R, Lee MJ, Taylor-Cousar JL Journal of Cystic Fibrosis 2022 Jul 21 662-668
    • Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design. Jain R, Magaret A, Vu PT, Vandalfsen JM, Keller A, Wilson A, Putman MS, Mayer-Hamblett N, Esther CR, Taylor-Cousar JL BMJ Open Respiratory Research 2022 Jun 9
    • Management of pregnancy in cystic fibrosis. Montemayor K, Tullis E, Jain R, Taylor-Cousar JL Breathe 2022 Jun 18
    • Pregnancy in cystic fibrosis: Review of the literature and expert recommendations. Jain R, Kazmerski TM, Zuckerwise LC, West NE, Montemayor K, Aitken ML, Cheng E, Roe AH, Wilson A, Mann C, Ladores S, Sjoberg J, Poranski M, Taylor-Cousar JL Journal of Cystic Fibrosis 2022 May 21 387-395
    • Understanding the Intersection between Gender Transition and Health Outcomes in Cystic Fibrosis. Shaffer LR, McCormack E, Sawicki GS, Keller A, Jain R Annals of the American Thoracic Society 2022 Mar 19 504-506
    • Engaging Stakeholders in the Development of a Reproductive Goals Decision AID for Women with Cystic Fibrosis. Stransky OM, Pam M, Ladores SL, Birru Talabi M, Borrero S, Godfrey EM, Roe AH, Sawicki GS, Zuckerwise LC, Mody S, Mentch L, Deal A, O’Leary R, Taylor-Cousar JL, Jain R, Kazmerski TM Journal of Patient Experience 2022 Feb 9
    • Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis. West NE, Kazmerski TM, Taylor-Cousar JL, Tangpricha V, Pearson K, Aitken ML, Jain R Pediatric pulmonology 2022 Feb 57 S89-S100
    • Family-building and parenting considerations for people with cystic fibrosis. Kazmerski TM, West NE, Jain R, Uluer A, Georgiopoulos AM, Aitken ML, Taylor-Cousar JL Pediatric pulmonology 2022 Feb 57 S75-S88
    • Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study. Goss CH, Fajac I, Jain R, Seibold W, Gupta A, Hsu MC, Sutharsan S, Davies JC, Mall MA European Respiratory Journal 2022 Feb 59
    • A randomized clinical trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment. Author Collaboration SI, Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA American journal of respiratory and critical care medicine 2021 Dec 204 1295-1305
    • Men's health in the modern era of cystic fibrosis. Khan FN, Tangpricha V, Hughan KS, Jain R, Ladores SL, Taylor-Cousar JL, West NE, Montemayor K, Sawicki GS, Uluer A, Aitken ML, Shnorhavorian M, Bray LA, Kvam C, Stalvey M, Kazmerski TM Journal of Cystic Fibrosis 2021 Nov 20 e121-e123
    • Challenges Faced by Women with Cystic Fibrosis. Jain R, Kazmerski TM, Aitken ML, West N, Wilson A, Bozkanat KM, Montemayor K, von Berg K, Sjoberg J, Poranski M, Taylor-Cousar JL Clinics in Chest Medicine 2021 Sep 42 517-530
    • Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. Author Collaboration Vs, Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE, Gibson RL, Rowe SM, Lechtzin N, Ahrens RC, McCoy KS, Aitken M, Donaldson SH, McBennett KA, Pilewski JM, Billings J, Milla C, Rubenstein R, Rosenbluth DB, Linnemann R, Powers MR, Fortner C, Frederick CA, Liou TG, Black P, Wang J, Colombo JL, Berdella M, Indihar MV, Brown CD, Anstead M, Bilodeau L, Sicilian L, Tolle JJ, Moffett K, Jain R The Lancet Respiratory Medicine 2021 Jul 9 733-746
    • A prospective study of the effects of sex hormones on lung function and inflammation in women with cystic fibrosis. Holtrop M, Heltshe S, Shabanova V, Keller A, Schumacher L, Fernandez L, Jain R Annals of the American Thoracic Society 2021 Jul 18 1158-1166
    • Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies. Bozkanat KM, West NE, Ladores S, Montemayor K, Tupayachi Ortiz MG, Christianson M, Jain R Respirology Case Reports 2021 Jun 9
    • Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation. Taylor-Cousar JL, Jain R Journal of Cystic Fibrosis 2021 May 20 402-406
    • Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis. Taylor-Cousar JL, Jain R, Kazmerski TM, Aitken ML, West NE, Wilson A, Middleton PG, Nash EF Journal of Cystic Fibrosis 2021 May 20 395-396
    • Fertility, pregnancy and lactation considerations for women with cf in the cftr modulator era. Jain R, Taylor-Cousar JL Journal of Personalized Medicine 2021 May 11
    • Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment. Harruff EE, Kil J, Ortiz MG, Dorgan D, Jain R, Poth EA, Fifer RC, Kim YJ, Shoup AG, Flume PA Journal of Cystic Fibrosis 2021 Mar 20 288-294
    • In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Nolan PJ, Jain R, Cohen L, Finklea JD, Smith TT Diagnostic Microbiology and Infectious Disease 2021 Feb 99
    • Gender-affirming hormone therapy in cystic fibrosis – A case of new Pseudomonas infection. Shaffer L, Bozkanat K, Lau M, Sharma P, Sathe M, Lopez X, Jain R Respiratory Medicine Case Reports 2021 Jan 32
    • Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development. Jain R, Baines A, Khan U, Wagner BD, Sagel SD Journal of Cystic Fibrosis 2021 Jan 20 50-56
    • Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients. Conrad DJ, Billings J, Teneback C, Koff J, Rosenbluth D, Bailey BA, Jain R Journal of Cystic Fibrosis 2021 Jan 20 91-96
    • End-of-Life Care in Cystic Fibrosis: Comparing Provider Practices Based on Lung Transplant Candidacy. Lange AV, Rueschhoff A, Terauchi S, Cohen L, Reisch J, Jain R, Finklea JD Journal of palliative medicine 2020 Dec 23 1606-1612
    • Caring for gender diverse youth with cystic fibrosis. Kidd KM, Sequeira GM, Voss RV, Weiner DJ, Ramsey BW, Jain R, Kazmerski TM Journal of Cystic Fibrosis 2020 Nov 19 1018-1020
    • An innovative phase ii trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor bi 1265162 in adults and adolescents with cystic fibrosis: Balance-cftm 1
    • Goss CH, Jain R, Seibold W, Picard AC, Hsu MC, Gupta A, Fajac I ERJ Open Research 2020 Oct 6 1-8. Access to coronavirus disease 2019 clinical trials by english and non-english speakers is needed. Jain MK, Rollins N, Jain R Clinical Infectious Diseases 2020 Oct 71 2298-2299
    • Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry. Godfrey EM, Mody S, Schwartz MR, Heltshe SL, Taylor-Cousar JL, Jain R, Sufian S, Josephy T, Aitken ML Contraception 2020 Jun 101 420-426
    • Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation. Reply. Jain R, Middleton PG, Rowe SM The New England journal of medicine 2020 Feb 382
  • Professional Activities

    • American College of Chest Physicians
    • American Thoracic Society
    • Association for Clinical and Translational Science (2009)
    • Dallas County Medical Society
    • Society for Women's Health Research (2012)
    • Texas Medical Association
  • Awards and Honors

    • D Magazine Best Doctor (2020-2022)
    • CREW award recipient (2010)
    • Dedman Family Scholar in Clinical Care (2010)
    • American Thoracic Society Career Development Award (2009)
    • Multidisciplinary Clinical Research Career Development Award (2009)
    • University of Texas Houston Health Science Center Gold Headed Cane Award - Humanism in Medicine (2001)

Where I Provide Care: